WASHINGTON — A federal appeals court ruled that three organizations, including the brand drug lobby PhRMA, can challenge Medicare’s drug price negotiation program in a lower court based in Texas.
STAT+: PhRMA scores a small win in legal challenge to Medicare’s drug price negotiation
An appeals court revived the challenge to Medicare's drug price negotiation program and sent it back to a lower court in Texas